Just out the results of our #metanalysis on the use of hormone replacement therapy in #breastcancer survivors. ‼️HR 1.46 for risk of disease recurrence 👉🏻subgroup analyses for subtypes of disease and type of HRT Marco Tagliamento Matteo Lambertini, MD PhD OncoAlert #bcsm link.springer.com/article/10.100…

#Immunotherapy with immune checkpoint inhibitors is associated with better quality of life than chemotherapy in our meta-analysis of 17 RCTs out now on European Journal of Cancer Thanks to my co-authors Andrea Boutros Enrica Tanda Luca Arecco, MD Matteo Lambertini, MD PhD ejcancer.com/article/S0959-…

#Immunoterapia vs #Chemioterapia: la prima garantisce una qualità di vita migliore perché stabilizza il #tumore, anche quando non lo riduce. La metanalisi di Andrea Boutros e Francesco Spagnolo pubblicata su European Journal of Cancer. OncoAlert Leggi di più: ospedalesanmartino.it/ricerca-scient…

Grazie a Ospedale San Martino Genova e GRAZIE a tutto il super gruppo dei coautori❗️ Francesco Spagnolo Enrica Tanda Luca Arecco, MD Matteo Lambertini, MD PhD Università di Genova

Proud to share this other OnCovid effort about the time-dependent improvement of COVID outcomes in pts with cancer Surgery and Cancer David James Pinato 🇺🇦 Alessandra Gennari MD PhD UPO - Università @prat_aleix Josep Tabernero Matteo Lambertini, MD PhD Tom Newsom-Davis jamanetwork.com/journals/jamao…

Proud to present our Università di Genova Ospedale San Martino Genova contribution for this super #SABCS21! ➡️ 3 Spotlight presentations ➡️ 9 Posters Looking forward for my 1st poster discussion with my prof Matteo Lambertini, MD PhD on #fertilitypreservation and life #after BC 🗓 Dec 8th - 5:00 PM CT OncoAlert

La #chemio minaccia le ovaie, un farmaco le protegge. Il trattamento è efficace e sicuro per le giovani donne colpite da #tumorealseno Studio di Matteo Lambertini, MD PhD e Lucia Del Mastro, supportato da fondi #5x1000 del @SanMartino_GE e da Fondazione AIRC per la ricerca sul cancro JNCI ospedalesanmartino.it/ricerca-scient…

The Multidisciplinary Management of Cutaneous Squamous Cell Carcinoma IMI - Intergruppo Melanoma Italiano provide a literature review and clinical recommendations mdpi.com/1446998 #mdpicancers Cancers MDPI #skincancer IRST "Dino Amadori" IRCCS Francesco Spagnolo Paolo A. Ascierto Pietro Quaglino Iris Zalaudek @mandalamario

Honored to receive the #BFSA2022 award and to present the results of our meta-analysis to such a great audience. Thanks to my professors and mentors Lucia Del Mastro and Matteo Lambertini, MD PhD 🙏🏼 Special thanks to Eva Blondeaux and all the co-authors for the support!

Proud to share again this 2020' 🇮🇹 collaboration recently awarded by Journal for ImmunoTherapy of Cancer Paolo A. Ascierto David James Pinato 🇺🇦 Alessandro Russo Francesco Spagnolo @raffaelegiusti Marco Filetti

So proud to share the latest work led by my friend Luca Arecco, MD fellow at Università di Genova Ospedale San Martino Genova online in ESHRE @OUPMedicine journal #HumReprod: #fertility preservation is safe in young #BreastCancer patients OncoAlert #UNIGEnonsiferma #SurvOnc #bcsm academic.oup.com/humrep/advance…

1/5 Thrilled to share our metanalysis finally published on ESHRE @OUPMedicine journal #HumReprod aiming to assess the #safety of fertility preservation techniques before and after anticancer treatments in young women with #breastcancer 📃Link: academic.oup.com/humrep/advance…

Approval of this new combination #immunotherapy for advanced melanoma patients will improve outcomes & likely impact cancer treatment globally. The next step is TGA Australia approval & consideration by the Pharmaceutical Benefits Advisory Committee (#PBAC) to be funded in Australia.

What a great news to celebrate your birthday Luca Arecco, MD !!! Congrats, very important data to improve the #oncofertility counseling of our young women with #BreastCancer OncoAlert Università di Genova #UNIGEnonsiferma #ospedalesanmartino #ResearchSavesLives #mentorshipIsKey #bcsm #SurvOnc

Our OncoAlert king giving a fantastic overview on #SoMe use in #oncology at the #YoungToYoung conference in beautiful #Meridiana palace in #Genova…so proud and excited to have you visiting us!!! ESMO - Eur. Oncology ESOncology Accademia Medicina Francesco Spagnolo Carlo Genova Università di Genova Ospedale San Martino Genova

Ciao #Liguria! Also known as the Italian Riviera, this region has a beautiful coastline featuring many picturesque port cities. Genoa and La Spezia are just two of them! #CiaoItaly #MissionMinerva European Space Agency ESA_Italia Human Spaceflight ESA Earth Observation International Space Station

1/3 Just published in The Lancet Oncology the 15-y follow-up data of #GIM2 trial: ✅ Impressive benefit both in #DFS (+8.5%) and #OS (+7%) rates of dose-dense adjuvant CT in high risk breast cancer patients.

Great presentation by our colleague and friend Andrea Boutros on 2nd day of this Young AIOM 2023 on melanoma. 🔎 focus on: 1. mRNA vaccine + Pembro promising adjuvant therapy 2. IPI+NIVO 1st standard line even in BRAFm 3. Tebentafusp standard tp for uveal metastatic melanoma

The Università di Genova Ospedale San Martino Genova crew at #ESMO23 🇮🇹❤️🤩💪🔝 Lucia Del Mastro ESMO - Eur. Oncology OncoAlert Marco Tagliamento Francesco Spagnolo Carlo Genova Diletta Favero Eva Blondeaux Roberto Borea, MD Davide Soldato Benedetta Conte

💫 What an honour to see our work on Early discontinuation of ICI in #elderly with #cscc cited by Teresa Amaral, MD, PhD during ESMO - Eur. Oncology session on survivorship in the era of #immunotherapy 🫶🏽 Università di Genova Ospedale San Martino Genova Francesco Spagnolo Matteo Lambertini, MD PhD Enrica Tanda Luca Arecco, MD